Summary
Samenvatting neurologische en locomotorische pathologie
- Course
- Institution
Volledige samenvatting van neurologische en locomotorische pathalogie gegeven door Michele Vergote
[Show more]
Seller
Follow
mariedekerf
Content preview
NEUROLOGISCHE EN LOCOMOTORISCHEPATHOLOGIE: MICHELE VERGOTE
1
,INHOUD
Inleiding neuropathologie ....................................................................................................................................... 7
Belangrijk kader neurologische pathologie ............................................................................................................................................ 7
Dwarslaesie ............................................................................................................................................................. 8
Inleiding.................................................................................................................................................................................................................. 8
Definitie .................................................................................................................................................................................................................. 8
Epidemiologie ................................................................................................................................................................................................... 10
Etiologie .............................................................................................................................................................................................................. 11
Prognose ............................................................................................................................................................................................................. 12
Omschrijving letsel ......................................................................................................................................................................................... 12
Neurologisch niveau ................................................................................................................................................................................. 13
Compleet/incompleet .............................................................................................................................................................................. 17
Klinische syndromen bij incomplete laesies ........................................................................................................................................ 18
Central cord syndrom............................................................................................................................................................................... 18
Anterior cord syndrom ............................................................................................................................................................................ 19
Posterior cord syndrom ........................................................................................................................................................................... 19
Hemicord syndrom = Brom-Sequard syndroom .......................................................................................................................... 20
Conus medullaris syndrom .................................................................................................................................................................... 20
Cauda equina syndroom ......................................................................................................................................................................... 21
Classificatie van lichamelijke gevolgen .................................................................................................................................................. 21
Gevolgen en stoornissen op lichamelijk vlak ...................................................................................................................................... 22
Blaasstoornissen ......................................................................................................................................................................................... 22
Decubitus....................................................................................................................................................................................................... 24
Spinale shockfase ....................................................................................................................................................................................... 25
Spasticiteit ..................................................................................................................................................................................................... 26
Circulatiestoornissen ................................................................................................................................................................................ 28
Seksuele stoornissen tem pijn (lezen in syllabus)......................................................................................................................... 30
Trombose ...................................................................................................................................................................................................... 30
Therapie............................................................................................................................................................................................................... 30
NAH (Niet-aangeboren hersenletsel) én CVA ................................................................................................. 31
Definitie NAH .................................................................................................................................................................................................... 31
THL = traumatisch hersenletsel ................................................................................................................................................................. 32
epidemiologie.............................................................................................................................................................................................. 32
Oorzaken ....................................................................................................................................................................................................... 33
Pathofysiologie ........................................................................................................................................................................................... 33
Ernst van het letsel .................................................................................................................................................................................... 35
Prognose hersenletsel .............................................................................................................................................................................. 37
2
, Niet responsieve waakzaamheid ......................................................................................................................................................... 38
Gevolgen NAH ............................................................................................................................................................................................ 39
CVA (HERSENINFARCT OF HERSENBLOEDING) ................................................................................................................................. 43
Vasularisatie van de hersenen .............................................................................................................................................................. 44
Epidemiologie.............................................................................................................................................................................................. 45
Enkele termen .............................................................................................................................................................................................. 46
Classificatie ................................................................................................................................................................................................... 47
Risicofactoren .............................................................................................................................................................................................. 48
Prognose........................................................................................................................................................................................................ 49
Gevolgen en stoornissen op lichamelijk vlak ................................................................................................................................. 49
Diagnose ........................................................................................................................................................................................................ 51
Behandeling CVA ....................................................................................................................................................................................... 52
Extra informatie........................................................................................................................................................................................... 52
ALS ......................................................................................................................................................................... 53
Definitie ............................................................................................................................................................................................................... 54
Epidemiologie ................................................................................................................................................................................................... 54
Etiologie .............................................................................................................................................................................................................. 54
Symptomen ....................................................................................................................................................................................................... 54
Klinisch beeld .................................................................................................................................................................................................... 55
Diagnose ............................................................................................................................................................................................................. 56
Prognose ............................................................................................................................................................................................................. 56
Behandeling ....................................................................................................................................................................................................... 57
Multiple Sclerose................................................................................................................................................... 57
Definitie MS ....................................................................................................................................................................................................... 57
Epidemiologie ................................................................................................................................................................................................... 58
Behandeling ....................................................................................................................................................................................................... 59
Subtypes van MS ............................................................................................................................................................................................. 59
Verloop en symptomen MS ........................................................................................................................................................................ 60
verloop............................................................................................................................................................................................................ 60
symptomen ................................................................................................................................................................................................... 61
Diagnose ............................................................................................................................................................................................................. 62
Extrapiramidale aandoeningen zoals Ziekte van Parkinson .................................................................................. 62
Parkinson ............................................................................................................................................................................................................ 62
Etiologie ......................................................................................................................................................................................................... 63
Epidemiologie.............................................................................................................................................................................................. 63
Fysiopathologie .......................................................................................................................................................................................... 64
Klinisch beeld ............................................................................................................................................................................................... 64
3
, Diagnose ........................................................................................................................................................................................................ 65
Behandeling ................................................................................................................................................................................................. 66
Prognose........................................................................................................................................................................................................ 67
Aandoeningen van het perifeer zenuwstelsel: letsels van het bovenste lidmaat (zelfstudie) .............................. 67
Inleiding............................................................................................................................................................................................................... 68
Innervatie van de arm .................................................................................................................................................................................... 68
Plexus brachialis letsel ................................................................................................................................................................................... 70
Laesie van de n.musculocuraneus ............................................................................................................................................................ 71
Laesie van de n.radialis ................................................................................................................................................................................. 72
Laesie van de n.medianus ............................................................................................................................................................................ 74
Laesie van de n.ulnaris .................................................................................................................................................................................. 77
Aard van het letsel .......................................................................................................................................................................................... 78
Prognose aandoeningen perifere zenuwstelsel ................................................................................................................................. 79
Reumatologie (start locomotorische pathologie) ................................................................................................. 79
De term ‘reuma’ ............................................................................................................................................................................................... 80
Artrose ................................................................................................................................................................................................................. 80
Epidemiologie.............................................................................................................................................................................................. 81
Pathofysiologie ........................................................................................................................................................................................... 82
Etiologie v. arthrosis deformans .......................................................................................................................................................... 82
Diagnose en behandeling ...................................................................................................................................................................... 83
Reumatoïde artritis ......................................................................................................................................................................................... 84
Epidemiologie en etiologie .................................................................................................................................................................... 84
Fysiopathologie .......................................................................................................................................................................................... 84
Symptomen .................................................................................................................................................................................................. 84
Diagnose en verloop ................................................................................................................................................................................ 85
Behandeling ................................................................................................................................................................................................. 85
Ziekte van Bechterew..................................................................................................................................................................................... 86
Epidemiologie en etiologie .................................................................................................................................................................... 86
Symptomen .................................................................................................................................................................................................. 87
Behandeling ................................................................................................................................................................................................. 87
Jicht ....................................................................................................................................................................................................................... 88
Fysiopathologie .......................................................................................................................................................................................... 88
Epidemiologie.............................................................................................................................................................................................. 88
Symptomen .................................................................................................................................................................................................. 89
Behandeling ................................................................................................................................................................................................. 89
Systemische lupus erythematosus (geen examenleerstof) ............................................................................................................ 89
Osteoporose ...................................................................................................................................................................................................... 89
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller mariedekerf. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $10.06. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
53022 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now